Bronchoscopic Interventional Therapy Combined With Pembrolizumab in the Treatment of Pulmonary Large Cell Neuroendocrine Carcinoma: A Case Report.

Yingyi FanYingying WangYanrong JiShuang LiJian ZhangXingliang Hao

Published in: The clinical respiratory journal (2024)

This study reports a significant clinical outcome following the use of bronchoscopic interventional therapy combined with pembrolizumab for treating pulmonary large cell neuroendocrine carcinoma (LCNEC), showcasing a novel approach in managing this aggressive cancer.

Keyphrases

cell therapy
single cell
pulmonary hypertension
advanced non small cell lung cancer
papillary thyroid
emergency department
squamous cell carcinoma
stem cells
bone marrow
squamous cell
combination therapy
replacement therapy